Clinical Trial Update: A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ETC 1002 for efficacy and safety in subjects with Type 2 Diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• ETC-1002 (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hyperlipidemia, Type 2 Diabetes | Phase 2 | Status: COMPLETED